Brimonidine Tartrate 1.5 mg, Stabilized, Oxychloro Complex 0.005% w/v Eye Drops

Brimonidine Tartrate 1.5 mg Eye Drops – ZEELAB Brimoz (5 mL)

ZEELAB Brimoz Eye Drops are prescription ophthalmic drops used to help reduce increased pressure inside the eyes in conditions such as glaucoma and ocular hypertension. They work by decreasing fluid production within the eye and improving fluid drainage.

Why Choose This Product
Brimonidine eye drops help support long-term eye pressure management and reduce the risk of optic nerve damage associated with elevated intraocular pressure.

Key Benefits

• Helps reduce elevated intraocular pressure

• Supports glaucoma and ocular hypertension management

• Helps protect optic nerve health

• Convenient ophthalmic drop formulation

• Suitable for long-term use under medical supervision

Key Ingredients

• Brimonidine Tartrate 1.5 mg – reduces pressure inside the eye

• Stabilized Oxychloro Complex 0.005% w/v – preservative system for stability

Suitable For

• Glaucoma patients

• Ocular hypertension management

• Adults under ophthalmologist supervision

How to Use

• Instill the prescribed number of drops into the affected eye(s)

• Use exactly as directed by an eye specialist

• Wash hands before use

• Avoid touching the dropper tip to any surface

Product Details

• Brand: ZEELAB

• Product Name: Brimoz Eye Drops

• Product Type: Ophthalmic Eye Drops

• Strength: Brimonidine Tartrate 1.5 mg + Stabilized Oxychloro Complex 0.005% w/v

• Net Quantity: 5 mL

• Category: Eye Care / Prescription Ophthalmic Drops

Safety Information

• For ophthalmic use only

• Use only under medical supervision

• Temporary blurred vision or irritation may occur

• Remove contact lenses before application if advised

• Keep out of reach of children

SEO Keywords
brimonidine eye drops India, brimoz eye drops India, glaucoma eye drops India, ocular hypertension eye drops India, eye pressure control drops India, prescription eye drops India

💡 Quick Insight
Regular eye pressure check-ups are important during glaucoma treatment, as elevated eye pressure may not cause noticeable symptoms initially.